Key Highlights: Implications: Nubeqa’s India approval intensifies mHSPC competition against Janssen’s Erleada, amid prostate therapeutics market growing at 8.2% CAGR to $739M by 2030. ...
Home / MetastaticCancer
Browsing Tag: MetastaticCancer
Featured Posts
1
Top 10 Indian BioPharma Companies of 2026
July 28, 20262
3
Sun Pharmaceutical Industries
July 27, 2026